CURRICULUM VITAE
MICHAEL UNGER, M.D., F.A.C.P., F.C.C.P.
PERSONAL
BUSINESS ADDRESS: Thomas Jefferson University
834 Walnut Str. Suite 650
Philadelphia, PA 19107
e -MAIL : mic****ger@jefferson.edu
BIRTHPLACE: Haifa, Israel
BIRTH DATE: 11 FEBRUARY 1944
CITIZENSHIP STATUS: United States, Israel
FOREIGN LANGUAGES: French, Hebrew, Polish, Russian
EDUCATION AND TRAINING
UNDERGRADUATE SCHOOL
Tel Aviv University
Tel Aviv, Israel Science
GRADUATE/PROFESSIONAL SCHOOL
University of Bordeaux
Medical School, Bordeaux, France 6/7/71 M.D.
GRADUATE MEDICAL EDUCATION
Intern in Medicine Wayne State University 1971-72
Detroit General Hospital
Detroit, Michigan
Resident in Medicine Mount Sinai Hospital 1972-74
Services City Hospital Center
at Elmhurst, New York, NY
Research and Clinical The New York Hospital- 1974-76
Fellowship in Pulmonary Diseases Cornell Medical Center
New York, NY
LICENSURE
New York MD 117945
Pennsylvania MD 018514E
BOARD CERTIFICATION
American Board of Internal Medicine 050979 1977
Pulmonary Disease 050979 1978
ACADEMIC HONORS AND AWARDS
Scholarship Award 35t,M.D. Degree awarded “With Highest Honors”
University of Bordeaux 1971
The 1983 Outstanding American College of Chest Physicians Motion Picture Award 1983
Howard Lilienthal American College of Chest Physicians Memorial Lecturer Award
New York State Chapter 1986
Honorary Member Award Singapore Academy of Medicine Honor Lecturer
and Visiting Professor 1988
Outstanding Teacher of the Year Award Pennsylvania Hospital 1997
Visiting Professor Silesian Medical Academy 2002
Visiting Professor Chinese Academy of Sciences 2006
ACADEMIC
Associate in Medicine, Department of Medicine, University 1976-77
of Pennsylvania School of Medicine
Assistant Professor of Medicine, Department of Medicine, 1977-81
University of Pennsylvania School of Medicine
Clinical Assistant Professor of Medicine, Department of 1981-85
Medicine, University of Pennsylvania School of Medicine
Clinical Associate Professor of Medicine, Department of 1985-91
Medicine, University of Pennsylvania School of Medicine
Clinical Associate Professor of Medicine, Thomas Jefferson 1991-1995
University, Jefferson Medical College
Clinical Professor of Medicine, Thomas Jefferson University, 1995- 2008
Jefferson Medical College
Professor at Fox Chase Cancer Center 1997- 2014
Professor of Medicine Thomas Jefferson University ,
Sidney Kimmel Medical School 2014 -
HOSPITAL
Associate Chief of Pulmonary Section, Presbyterian- 1976-81
University of Pennsylvania Medical Center
Medical Director of Respiratory Therapy Department, 1976-82
Presbyterian-University of Pennsylvania Medical
Center
Acting Chief of Pulmonary Section, Presbyterian- 1981-82
University of Pennsylvania Medical Center
Medical Director of Pulmonary Function Laboratory 1982-85
and Arterial Blood Gas Laboratory, Presbyterian-
University of Pennsylvania Medical Center
Director, Laser Research and Development for 1985-97
Medical Diseases, Pennsylvania Hospital
Director of Pulmonary Endoscopy, Pennsylvania 1985-97
Hospital
Director, Pulmonary Cancer Detection and 1997-2014
Prevention Program, Fox Chase Cancer Center
Director, Pulmonary Endoscopy and High 1997-2014
Risk Lung Cancer Program, Fox Chase Cancer Center
PROFESSIONAL ACTIVITIES
EDUCATIONAL
ME364A Elective Course in Clinical Pulmonary Disease
ME 200 Clinical Medicine Lectures
Teaching Attending Physician on the Internal Medicine Service
Continuous Educational Seminars in Respiratory Therapy
Teaching Attending in the I.C.U.
I.C.U. Critical Care Course
Medical Grand Rounds Lectures
Pulmonary Conferences
Laser Seminars and Workshops Director
Pulmonary Hypertension Workshops
Chair Scientific Committee WCB
RESEARCH
GRANT SUPPORT
The Effects of PGB-x in Shock Lung and in
Hypoxia-Induced Pulmonary Hypertension,
United States Navy $29,410.00 1978
Photodynamic Therapy of Lung Carcinoma,
American Cyanamid Company, Lederle
Laboratories $16,000.00 1991
Photodynamic Therapy and Early Detection
of Cancer, Theodore B. Betz Foundation $450,000.00 1993
Determination of Lung Cancer Susceptibility among High Risk Female Smokers. Correlation of CYP1A1 Polymorphism and Abnormal Autofluorescence. Bristol- Myers Squibb Foundation, Better Health For Women: A Global Health Program $ 200,000.00 1999
PROFESSIONAL ORGANIZATIONS
LOCAL, REGIONAL, NATIONAL
1973 American College of Physicians- Fellow
1974 American Thoracic Socity
1974 New York Trudeau Society
1974 Eastern Section, American Thoracic Society
1976 Laennec Society (President 1999)
1978 American Federation for Clinical Research
1981 New York Academy of Sciences
1982 American College of Chest Physicians
1982 American Society for Laser Medicine and Surgery
1982 Philadelphia College of Physicians
1986 International Photodynamic Association (Board Member)
1987 Montgomery County Medical Society
1990 Philip Drinker Society (Critical Care)
1994 American Association for Bronchology (Board Member)
1995 World Association for Bronchology ( Board Member)
1999 International Association for the Study of Lung Cancer
2008 Health and Sciences Committee ACCP
COMMITTEES
HOSPITAL
Presbyterian-University of Pennsylvania Hospital:
Continuing Education Committee
Quality Assurance Committee 1977
Patient Care Review Committee 1979
Intensive Care Unit Committee 1981
Library Committee 1981
Medical Staff Committee
Chairman, Laser Committee
Pennsylvania Hospital:
Laser Committee 1985
By-Laws Committee
Ethics Committee 1988
Infection Control Committee
Patient Care Committee 1993
Tumor Committee 1996
Ethics Committee
Critical Care Committee 1997
Fox Chase Cancer Center:
Laser Committee 1997
Operating Room Committee
Ethics Committee
IT Implementation Committee
Keystone Executive Committee
Promotion Committee
Institutional Review Committee
Journal of Bronchology 1994-2006
Lasers in Surgery and Medicine 1995-1999
Chest 2001-2009
Annals of Internal Medicine ( Associate Editor) 2009-present
PUBLICATIONS
PEER-REVIEWED ARTICLES
1. Unger, M.: Hemangioblastome multiple, cerebellar et medulare, Doctoral Thesis, University of Bordeaux, 1971.
2. Unger, M., Atkins, M., Briscoe, W.A., King, T.K.C.: Potentiation of pulmonary vasoconstrictor response with repeated intermittent hypoxia, Journal of Applied Physiology 43: 662-667, 1977.
3. Parr, G.V.S., Unger, M., Trout, R., Atkinson, G.W.: One hundred neodymium-YAG laser ablations of obstructing tracheal neoplasms, The Annals of Thoracic Surgery 38: 374-38, 1984. (Presented at the 20th Annual Meeting of the Society of Thoracic Surgery, San Antonio, TX, January, 1984).
4. Mohr, R.M., McDonnell, B.C., Unger, M., Mauer, T.P.: Safety considerations and safety protocol for laser surgery, Surgical Clinics of North America 64:851-859, 1984.
5. Unger, M.: Bronchoscopic utilization of the Nd:YAG laser for obstructing lesions of the trachea and bronchi, Surgical Clinics of North America 64: 931-938, 1984.
6. Kirschner, R.A., Unger, M.: Introduction to laser surgery, Surgical Clinics of North America 64: 839-841, 1984.
7. Kirschner, R.A., Unger, M., Imber, P.: An introduction to dye lasers and photoradiation therapy, Surgical Clinics of North America 64: 939-940, 1984.
8. Duckett, J.E., McDonnell, T.J., Unger, M., Parr, G.V.S.: General anesthesia for Nd:YAG laser resection of obstructing endobronchial tumors using the rigid bronchoscope, Canadian Anesthetists Society Journal 32: 67-72, 1985.
9. Unger, M.: Neodymium: YAG laser therapy for malignant and benign endobronchial obstructions, Clinics in Chest Medicine 6: 277-295, 1985.
10. Zatuchni, J., Patel, H.K., Unger, M.: Nd:YAG laser treatment of endobronchial lipoma in a patient with metastatic adenocarcinoma of the prostate, Houston Medical Journal 2: 25-28, 1986.
11. Unger, M., Parr, G.V.S.: The benefits of Nd:YAG laser application for end-stage patients, Tumor Diagnostic & Therapy 7: 13-16, 1986.
12. Carson, S.L., Unger, M., Kwa, D., et al: Laparoscopic laser treatment of endometriosis with the Nd:YAG sapphire probe, American Journal of Obstetrics and Gynecology 160: 718-723, 1989.
13. Derbyshire, G.J., Bogen, D.K., Unger, M.: Thermally induced optical property changes in myocardium at l.06 um, Lasers in Surgery and Medicine l0: 28-34, l990.
14. Clark, J.M., Jackson, R.M., Lambertsen, C.J., Gelfand, R., Hiller, D.W.B., Unger, M.: Pulmonary function in man after oxygen breathing at 3.0 ATA for 3.5 hours, Journal of Applied Physiology 71:878-885, 1991.
15. Altman, H., Pietra, G., LiVolsi, V., Kelley, M., Unger, M., Hayden, R.: Tracheobronchial Inflammatory Myofibroblastoma: A locally invasive, potentially recurrent neoplasm, Int. J. Surg.Pathol. 2 (2): 93-98, 1994.
16. Unger, M: Rigid versus flexible bronchoscopy in laser bronchoscopy: Pro flexible bronchoscopic laser application. J Bronchol 1:69-71,1994.
17. Unger, M., "Clinically relevant technology in photodynamic therapy and photodynamic diagnosis",in 5th International Photodynamic Association Biennial Meeting, Denis A. Cortese, Editor, Proc. SPIE 2371, 16-21 (1995).
18. Unger, M., Gincherman, Y., Kussmaul, W.: Balloon bronchoplasty for management of bronchial stenosis (submitted for publication).
19. Sterman, D., Unger, M., Schiffman, R.: Pulmonary carcinoid tumors and their therapy with laser (submitted for publication).
20. Lam, S., Unger, M., Kennedy T., Miller, Y.E., Gelmont, D., Rusch, V., Grippe, B., Howard, D., LeRichie, J.C., Coldman, A., Gazdar, A.F.: Localization of bronchial epithelial neoplastic lesions by fluorescence endoscopy ,Chest 113: 696-702, 1998.
21. Snyder, R., Unger, M., Sawicki, R.: Bilateral partial bronchial obstruction due to broncholithiasis treated with laser therapy, Chest.113: 240-2, 1998
22. Schnall R.A, Malstrom M, Lames C, Rothman R.L, Miller S.A, Ridge J.A, Movsas B, Unger M, Langer C, Goldberg M.: Correlates of tobacco use among smokers and recent quitters diagnosed with cancer, Patient education & Counseling, 46:137-145,2002
23. Schnall R.A, Malstrom M, James C, Rothman R.L, Miller S.M, RidgeJ.A, Movsas B, Langer C, Unger M, Goldberg M: Process of change related to smoking behavior among cancer patients. Cancer Practice 10: 11-19,2002
24. Schnall R.A, Miller S.M, Unger M, McAleer C, Halbherr T, Bradley P: Characteristics of female smokers attending a lung screening program: a pilot program with implications for program development. Lung Cancer37: 257-265,2002
25. Colice GL, Rubins J, Unger M: Follow-up and surveillance of the lung cancer patient following curative-intent therapy. Chest 2003:272S-283S
26. Schnoll R.A., Bradley, P., Miller, S.M., Unger, M., Babb, J., & Cornfeld, M. Psychological issues related to the use of spiral CT for lung cancer early detection. Lung Cancer39: 315-325,2003
27. Schnoll R.A, James C, Malstrom M, Rothman R L, Wang H, Babbs J, Miller AM, Ridge JA, Movsas B, Langer C, Unger M, Goldberg M: Longitudinal predictors of continued tobacco use among patients diagnosed with cancer. Ann Behav Med 25: 214-221,2003
28. Schnoll RA, Rothman R.L, Lerman C, Miller A>M, Newman H. Movsas B, Sherman E, Ridge J.A, Unger M, Langer C, Goldberg M Scott W. Cheng J. Comparing Cancer Patients who enrol in Smoking cessation program at comprehensive cancer center with those who decline enrolment. Head Neck 26:278-286,2004
29. Schnoll, R.A., Rothman, R.L. , Newman, H., Lerman, C., Miller, S.M., Movsas, B., Sherman, E. Ridge, J.A., Unger, M. Langer, C., Goldberg, M., Scott, W. & Cheng, J. Characteristics of cancer patients entering a smoking cessation program and correlates of quit motivation. Psycho-Oncology 13: 346-358,2004.
30. Balsara BR, Pei J, Mitsuuchi Y, Page R, Klein-Szanto A, Wang H, Unger M, Testa JR. Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions. Carcinogenesis: 25: 2053 - 2059,2004
31. Schnoll,R.A.,Rothman ,R.L., Wielt, M.A., Lerman, C., Pedri, H, Wang,H., Babb,J., Miller,S.M., Movsas, B., Sherman, E., Ridge, J. A., Unger, M., Langer, C., Goldberg, M., Scott, W., Chang, J. A randomized pilot study of cognitive –behavioral therapyversus basic health education for smoking cessation among cancer patients. Ann Behav Med 30:(1):1-11,2005
32. Unger, M. A Pause, Progress and Reassessment in Lung Cancer Screening. N Engl J Med 355:17;1822-1824, 2006
33. Unger, M. Role of Biology and genetics in lung cancer in women. J Thorac Oncol 2:8:Suppl 4: S192-193
34. Freitag L,Ernst A, Unger M, Kovitz K, Marquette C H: A proposed classification system of central airway stenosis. Eur Respir J: 30: 7-12, 2007
35. Colice GL, Rubins J, Unger M: Follow-up and surveillance of the lung cancer patient following curative-intent therapy. Guidelines. Chest 132; 355S-367,2007
36. Unger M: Expert Insight Into: Minimally Invasive Endoscopic Staging of Suspected Lung Cancer
|
Advanced Certificate Program; Lung Cancer Management, Projects in Knowledge, Curriculum II |
Article Review (Course LC02.07) Feb 2009
37. Unger M: Case Study: NSCLC (Squamous Cell Carcinoma) in a Patient with COPD— Advanced Certificate Program; Lung Cancer Management, Projects in Knowledge, Curriculum II (Course LC02.16) Aug 2009
38. Herbst R, Langer C, Gore E, Shrager J, Unger M: Management of Stage III, N2 NSCLC: A Virtual Thoracic Oncology Tumor Board— Advanced Certificate Program; Lung Cancer Management, Projects in Knowledge, Curriculum II Webcast (Course LC02.14), June 200918
39. Cohen RJ, Sharma NK, Yu M, Wang L, Buyyounouski M, Unger M, Borgheai HA, King E, Scott W, Callahan E, Movsas B, Feigenberg S: Phase I Radiation Dose Escalation of Stereotactic Body Radiotherapy for Malignant l Lung Tumors. J Bio SCI Eng 2010,3,351-358
40. Wood DE, Eapen GA, Ettinger DS, Hou L, Jackman D, Kazerooni E, Klippenstein D, Lackner RP,
Leard L, Leung AN, Massion PP, Meyers BF, Munden RF, Otterson GA, Peairs K, Pipavath S,
Pratt-Pozo C, Reddy C, Reid ME, Rotter AJ, Schabath MB, Sequist LV, Tong BC, Travis WD,
Unger M, Yang SC. Lung cancer screening. JNCCN 2012;10;240-265
41. Henri G. Colt, Septimiu D. Murgu, Robert J. Christopher G. Michael Unger; Silvia Quadrelli, Follow-up and Surveillance of the Patient With Lung Cancer After Curative-Intent Therapy: Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2013; 143(5_suppl):e437S-e454S. doi:10.1378/chest.12-2365
Videos:0
Abstracts:1
638
0
0
Date | Time | Local Time | Room | Session | Role | Topic |
---|---|---|---|---|---|---|
2020-11-21 | 13:55-14:20 | 2020-11-21,13:55-14:20 | Room No. 2 |
The Science of IP: Theory and Technology |
Speaker | Laser Technology-How It Works in Biologic Systems |